Abstract
Although aspirin use has become an established therapy for the secondary prevention of cardiovascular disease, newer evidence has influenced recommendations regarding the use of aspirin for primary prevention of cardiovascular disease in high-risk patients.
Article Extract
Diabetes remains an ever-increasing global epidemic with over 422 million people affected worldwide and requiring over $827 billion of global health expenditure annually.1 In Australia, over 1.7 million people are living with diabetes, including an estimated 500,000 people who are currently undiagnosed.2,3 Diabetes is associated with a range of acute and chronic complications that contribute to increased morbidity and mortality.1
